Takara Bio Inc.

Company Overview

Takara Bio Inc. is a Japan-headquartered life science tools company that produces and sells research reagents and scientific instruments, and it also operates CDMO and gene therapy-related activities.

In the protein labeling market, Takara Bio Inc. primarily participates through tag-enabled protein workflows and fluorescence-linked analysis tools. Its portfolio includes cobalt-based metal affinity resins used to purify and capture His-tagged proteins (TALON products), which support routine protein interaction and downstream detection workflows. It also offers fluorescence labeling reagents for glycan-associated protein analysis, including a kit for fluorescent derivatization of sialic acids (DMB labeling), enabling sensitive HPLC-based quantification in glycoprotein and glycolipid samples.

Financial Highlights (FY 2024)

Company's Business Segments

• Reagents : Research Reagents, Academic, Corporate, Basic research, Advance Research, Life sciences, Biologic development, Applied Research.
• Instruments : Scientific instruments, Academic, Corporate, Clinical laboratories, Medical Institutions, Pathogens, Advance research.
• CDMO : Contract services related to Regenerative medicine products, manufacturing and development of viral, plasid vectors, Gene cells, Quality testing, Safety testing. Biologics development, bio ventures, other research.
• Gene Therapy : Takara Bio aims to maximize the value of its propriertary platform technology for biologics development and purse practical applications for Gene Therapy.